
Retatrutide: The Triple Agonist That Outperforms Every GLP-1 on the Market
Most weight loss interventions treat the symptom. Retatrutide addresses the system.
In this episode of Unbreakable Vitality, we break down why Retatrutide, a first-in-class triple hormone receptor agonist, is becoming a cornerstone of precision metabolic medicine for high-performers with stubborn visceral fat, insulin resistance, and inflammatory markers that won't budge despite optimized lifestyle.
This episode covers: why Retatrutide outperforms Semaglutide and Tirzepatide, how we prepare the metabolic terrain before prescribing it, and the full biomarker panel we use to protect lean mass…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.